SCIENTURE HOLDINGS, INC. Accrued Liabilities, Current
SCIENTURE HOLDINGS, INC. (SCNX) had Accrued Liabilities, Current of $503.63 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $503.63K.
- 2026-03-31: Accrued Liabilities, Current $703.87K.
- 2025-12-31: Accrued Liabilities, Current $657.03K.
- 2025-09-30: Accrued Liabilities, Current $984.83K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $503.63K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $703.87K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $657.03K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $984.83K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.80M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.41M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.31M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $500.45K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $493.40K 10-Q · filed 2024-06-26 | |
| 2023-12-31 | $160.21K 10-K · filed 2025-03-26 | $400.99K 10-K · filed 2024-04-22 |
| 2023-09-30 | $386.02K 10-Q · filed 2024-01-16 | |
| 2023-06-30 | $376.31K 10-Q · filed 2023-08-18 | |
| 2023-03-31 | $303.23K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $271.23K 10-K · filed 2024-04-22 | $290.01K 10-K · filed 2023-03-27 |
| 2022-09-30 | $312.08K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $437.29K 10-Q · filed 2022-07-25 | |
| 2022-03-31 | $344.94K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $270.44K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $316.08K 10-Q · filed 2021-10-25 | |
| 2021-06-30 | $377.05K 10-Q · filed 2021-07-26 | |
| 2021-03-31 | $519.18K 10-Q · filed 2021-04-26 | |
| 2020-12-31 | $219.26K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $286.14K 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $349.85K 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $233.56K 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $98.85K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $151.10K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $101.19K 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $177.61K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $138.32K 10-K · filed 2020-03-30 | |
| 2018-06-30 | $160.45K 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $174.12K 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $156.96K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $199.74K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $166.23K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $282.27K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $466.98K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $645.71K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $608.86K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $396.48K 10-Q · filed 2016-04-20 | |
| 2015-12-31 | $248.39K 10-K · filed 2017-03-30 | $296.80K 10-K · filed 2016-03-28 |
| 2015-09-30 | $273.89K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $209.04K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $182.12K 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $175.79K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $109.04K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $139.29K 10-Q · filed 2014-08-21 | |
| 2013-12-31 | $37.97K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |